Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Management of onchocerciasis among adolescents in nkwanta north district of Ghana: Qualitative study of adolescents’ perception, community and health system support

Gbogbo S, Amu H, Dowou RK, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2023; 17 (8) : 1-16.
Download PDF
Publication

A mixed method analysis of the Botswana schistosomiasis control policy and plans using the policy triangle framework.

Gabaake K, Lucero-Prisno D, Thakadu O, et al. Global health research and policy. 2023; 8 (1) : 1-13.
Download PDF
Publication

No secondary impact of ivermectin mass drug administration for onchocerciasis elimination on the prevalence of scabies in northwestern Ethiopia.

Yirgu R, Middleton J, Fekadu A, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2023;
Publication

How and why snakebite became a global health priority: a policy analysis.

Bhaumik S, Zwi A, Norton R, et al. BMJ global health. 2023; 8 (8) : 1-14.
Download PDF
Publication

How important is the spatial movement of people in attempts to eliminate the transmission of human helminth infections by mass drug administration?

Collyer B, Truscott J, Mwandawiro C, et al. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2023; 378 (1887) : 1-9.
Download PDF
Publication

Reaching the World Health Organization elimination targets for schistosomiasis: the importance of a One Health perspective

Díaz AV, Walker M, Webster JP. The Royal Society. Philosophical Transactions of the Royal Society B: Biological Sciences. 2023; 378 (1887) : 1-11.
Download PDF
Publication

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin

Otabil KB, Ankrah B, Bart-Plange EJ, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2023; 12 (1) : 1-14.
Download PDF
Publication

Organising for One Health in a developing country

Mor N. Elsevier BV. One Health. 2023;
Download PDF
Publication

Effects of the suspension of mass drug administration during the COVID-19 pandemic on onchocerciasis prevalence in the Bandjoun and Massangam health districts, West Region of Cameroon

Shintouo CM, Shey RA, Yengo BN, et al. Elsevier BV. Acta Tropica. 2023;
Publication

Cultural adaption and validation of the Explanatory Model Interview Catalogue–Community Stigma Scale in the assessment of public stigma related to schistosomiasis in lakeshore areas of Mwanza region, Tanzania

Klinker L, Boeckler A, Kreibich S, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2023; 17 (8) : 1-21.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 70
  • Next page ››
Subscribe to African Region (AFR)

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD